Cedars-Sinai Health Ventures was among the investors in a $61 million series B financing round July 11 for Regard, which already counts several health systems as clients. The startup has been valued at $350 million, TechCrunch reported.
“Cedars-Sinai has been working alongside Regard from the early days of the business because we saw a real need to empower physicians with the data that can provide critical analysis and insights to assist in diagnosis and treatment,” said Maureen Burgess, partner at Cedars-Sinai Health Ventures, in a statement. “And, even more importantly, we believe it will improve patient care as well as the patient experience.”
Regard’s other health system customers include Phoenix-based Banner Health, Norfolk, Va.-based Sentara Health, and Raleigh, N.C.-based WakeMed. The company said it is at the vanguard of what comes next after AI scribes, revealing clinical insights from all that new EHR data.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
